Schedule 13D ownership disclosure

Cytek Biosciences Inc

Security class unavailable · CUSIP: 23285D109

Event date: 2021-07-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,607,028
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-101483
Form type
SC 13D
Filer
Cytek Biosciences, Inc.
CIK
CIK 1831915
Filed
Aug 06, 2021
Reporting period
Jul 27, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub